Should we treat cholestatic liver disease with cholesterol synthesis inhibitors?
Schmidt
H H
HH
Manns
M P
MP
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D002779:Cholestasis / Q000188:drug therapy*; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid